IL10 and myeloid sarcoma: Individuals with MS are treated by a multidisciplinary team in an individual manner.[18] However, medical and physiotherapeutic treatments are limited and new therapeutic modalities are needed to impede the progression of the disease.[10] The present study demonstrated that both forms of irradiation were effective at increasing the expression of IL-10 and may be used to complement the management of MS.